IP Library Granted Patent US 11,607,520
Granted Patent B2
US 11,607,520 · App. 16/247,516 · Granted Mar 21, 2023

Delivery of ultra pure nitric oxide (NO)

Inventors: David H. Fine (Cocoa, FL); Gregory Vasquez (Cocoa, FL); Bryan Johnson (Orlando, FL); Ryan Denton (Titusville, FL); Lucas G. Gamero (Oviedo, FL)
Assignee: VERO Biotech Inc.
A61M16/122A61M16/10A61M16/12C01B21/24A61M16/0666A61M16/105A61M16/107A61M16/1055A61M16/1075A61M2016/0027A61M2016/102A61M2202/0266A61M2202/0275A61M2202/03A61M2205/0238A61M2205/18A61M2205/3368A61M2205/3653A61M2205/7518A61M2205/8206A61M2207/10A61M2209/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,607,520
App. No.
16/247,516
Granted
Mar 21, 2023
Kind
B2
Abstract

A system for delivering a therapeutic amount of nitric oxide can include a reservoir containing a nitrogen dioxide source. A heating element can be configured to heat the reservoir, causing nitrogen dioxide vapor to exit the reservoir through a restrictor into a conduit. The nitrogen dioxide vapor can mix with gas from a gas supply, which can then flow to a cartridge that includes a surface-activated material saturated with an aqueous solution of a reducing agent. The cartridge can convert the nitrogen dioxide into nitric oxide.

Claims (34)

1. A method, comprising:

heating a reservoir containing dinitrogen tetroxide, the reservoir coupled to a first end of a restrictor, a second end of the restrictor being sealable;

opening the second end of the restrictor;

releasing nitrogen dioxide from the reservoir via the restrictor into a delivery conduit;

flowing a gas from a gas supply into the delivery conduit to cause the gas from the gas supply and the nitrogen dioxide to form a gas mixture in the delivery conduit;

converting the nitrogen dioxide to nitric oxide by flowing the gas mixture through at least one cartridge that includes a surface-activated material and a reducing agent; and

delivering nitric oxide from an outlet of the delivery conduit.

2. The method of claim 1 , wherein the restrictor includes a capillary tube.

3. The method of claim 1 , wherein the restrictor includes a valve configured to selectively open the second end of the restrictor.

4. The method of claim 3 , further comprising flowing the gas mixture through at least one of a nitric oxide sensor, a nitrogen dioxide sensor, a flow sensor, a temperature sensor, or a pressure sensor.

5. An apparatus comprising:

a gas supply;

a reservoir containing dinitrogen tetroxide;

a heating element configured to heat the reservoir;

a restrictor, including a first end of the restrictor coupled to the reservoir and a second end of the restrictor being sealable; and

a delivery conduit coupled to the restrictor and configured to deliver nitric oxide, the delivery conduit including (1) an inlet coupled to the gas supply and configured to receive nitrogen dioxide, (2) a cartridge including a surface-activated material and a reducing agent, the cartridge configured to convert nitrogen dioxide to nitric oxide, and (3) an outlet configured to deliver nitric oxide.

6. The apparatus of claim 5 , wherein the restrictor is a capillary tube.

7. The apparatus of claim 6 , wherein the restrictor is made of quartz or glass.

8. The apparatus of claim 6 , wherein the restrictor is beveled or scored to allow the opening of the second end sealed.

9. The apparatus of claim 6 , wherein the gas supply is an air pump.

10. The apparatus of claim 5 , wherein the restrictor includes a valve configured to open the second end.

11. The apparatus of claim 5 , wherein the gas supply is an air supply.

12. The apparatus of claim 5 , wherein the delivery conduit includes at least one of a nitric oxide sensor, a nitrogen dioxide sensor, a flow sensor, a temperature sensor, a pressure sensor, or a sensor for atmospheric pressure.

13. The apparatus of claim 5 , wherein the reservoir, the restrictor, and the cartridge form a disposable module capable of being removed from the apparatus.

14. The apparatus of claim 5 , wherein the outlet is coupled to a patient interface.

15. An apparatus comprising:

a gas supply;

a restrictor having a second end that is sealable;

a reservoir including dinitrogen tetroxide, the reservoir coupled to a first end of the restrictor;

a heating element;

a circuit board configured to adjust a temperature of the reservoir using the heating element; and

a delivery conduit coupled to a second end of the restrictor and configured to deliver nitric oxide, the delivery conduit including (1) an inlet coupled to the gas supply and configured to receive nitrogen dioxide, (2) a cartridge including a surface-activated material and a reducing agent, the cartridge configured to convert nitrogen dioxide to nitric oxide, and (3) an outlet configured to deliver nitric oxide.

16. The apparatus of claim 15 , wherein the circuit board includes a thermistor configured to measure the temperature of the reservoir.

17. The apparatus of claim 15 , wherein increasing the temperature of the reservoir assembly is configured to increase a concentration of nitric oxide delivered via the delivery conduit.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2020
From: FINE, DAVID H.; VASQUEZ, GREGORY; JOHNSON, BRYAN; DENTON, RYAN; GAMERO, LUCAS G.
To: GENO LLC
Reel/Frame 053889/0580 →
CHANGE OF NAME Recorded Sep 25, 2020
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 053891/0628 →
Continuity (4)
Continuation 14546373 · Nov 18, 2014
Continuation 13094535 · Apr 26, 2011
Provisional Application 61328010 · Apr 26, 2010
Related Publication 20190217043A1 · Jul 18, 2019